VINCERX PHARMA, INC.

Analyst Reco. Vincerx Pharma, Inc.

Equities

VINC

US92731L1061

Market Closed - Nasdaq Other stock markets 21:00:00 29/04/2024 BST			5-day change	1st Jan Change
0.8401 ^USD	+15.08%		-3.33%	-28.81%

04-26	Tech Rally Boosts Exchange-Traded Funds, Equity Futures Pre-Bell Friday	MT
04-26	Vincerx Pharma Prices Public Offering of Shares, Warrants	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Chardan Trims Price Target on Vincerx Pharma to $3 From $4, Keeps Buy Rating	17/11/22	MT
SVB Securities Adjusts Vincerx Pharma's Price Target to $5 From $6, Keeps Outperform Rating	12/08/22	MT
Cantor Fitzgerald Adjusts Vincerx Pharma's Price Target to $8 From $22, Reiterates Overweight Rating	08/06/22	MT
Chardan Cuts Price Target on Vincerx Pharma to $4 From $11 as it Shifts VIP152 Launch to 2026 From 2024 Reiterates Buy Rating	07/06/22	MT
SVB Securities Adjusts Vincerx Pharma's Price Target to $6 From $19, Keeps Outperform Rating	07/06/22	MT
B. Riley Adjusts Vincerx Pharma Price Target to $6 From $12, Maintains Buy Rating	07/06/22	MT
Chardan Cuts Price Target on Vincerx Pharma to $4 From $11 on Adjusted VIP152 Estimates, Reiterates Buy Rating	07/06/22	MT
Chardan Lowers Vincerx Pharma's Price Target to $11 From $14, Buy Rating Kept	13/05/22	MT
B. Riley Lowers Vincerx Pharma's Price Target to $12 from $26, Says May Need to Raise Additional Capital Under Unfavorable Conditions; Keeps Buy Rating	12/04/22	MT
SVB Leerink Adjusts Vincerx Pharma's Price Target to $20 from $24, Keeps Outperform Rating	30/03/22	MT
HC Wainwright Adjusts Vincerx Pharma's Price Target to $28 From $25, Reiterates Buy Rating	30/03/22	MT
HC Wainwright Starts Vincerx Pharma at Buy With $25 Price Target	14/01/22	MT
Cantor Fitzgerald Starts Vincerx Pharma at Overweight With $25 Price Target	23/12/21	MT
SVB Leerink Starts Vincerx Pharma at Outperform with $24 Price Target	01/11/21	MT
VINCERX PHARMA : Laidlaw & Co. Starts Vincerx Pharma at Buy with $30 Price Target	13/09/21	MT
VINCERX PHARMA : B. Riley Starts Vincerx Pharma at Buy with $26 PT, Says Shares Offer 'Attractive' Entry Point Ahead of VIP152 Clinical Updates; Keeps Buy Rating	25/08/21	MT
VINCERX PHARMA : Chardan Adjusts Price Target on Vincerx to $30 From $33, Citing 'Forward OpEx Estimates, Recent Dilution;' Buy Rating Kept	13/08/21	MT
VINCERX PHARMA : Chardan Starts Vincera Pharma at Buy With $33 Price Target	06/01/21	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019

Replicate our performance

fermer